Shah PK, Prabhu V, Narendran V. Outcomes of transconjuctival sutureless 27-gauge vitrectomy for stage 4 retinopathy of prematurity. World J Clin Pediatr 2018; 7(1): 62-66 [PMID: 29456934 DOI: 10.5409/wjcp.v7.i1.62]
Corresponding Author of This Article
Dr. Parag K Shah, DNB, Department of Pediatric Retina and Ocular Oncology, Aravind Eye Hospital, Avinashi Road and Postgraduate Institute of Ophthalmology, Coimbatore, Tamil Nadu 641014, India. parag@cbe.aravind.org
Research Domain of This Article
Pediatrics
Article-Type of This Article
Clinical Practice Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Pediatr. Feb 8, 2018; 7(1): 62-66 Published online Feb 8, 2018. doi: 10.5409/wjcp.v7.i1.62
Outcomes of transconjuctival sutureless 27-gauge vitrectomy for stage 4 retinopathy of prematurity
Parag K Shah, Vishma Prabhu, Venkatapathy Narendran
Parag K Shah, Vishma Prabhu, Venkatapathy Narendran, Department of Pediatric Retina and Ocular Oncology, Aravind Eye Hospital, Coimbatore, Tamil Nadu 641014, India
Author contributions: All authors equally contributed to this paper with regard to study conception and design, literature review and analysis, manuscript drafting, critical revision, and editing, and final approval of the final version.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of Aravind Eye Hospital.
Informed consent statement: The participating patients provided informed consent and gave permission for publication.
Conflict-of-interest statement: We have no financial relationships to disclose.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Parag K Shah, DNB, Department of Pediatric Retina and Ocular Oncology, Aravind Eye Hospital, Avinashi Road and Postgraduate Institute of Ophthalmology, Coimbatore, Tamil Nadu 641014, India. parag@cbe.aravind.org
Telephone: +91-422-4360400 Fax: +91-422-2593030
Received: November 2, 2017 Peer-review started: November 2, 2017 First decision: November 30, 2017 Revised: December 3, 2017 Accepted: December 14, 2017 Article in press: December 14, 2017 Published online: February 8, 2018 Processing time: 96 Days and 14.9 Hours
Abstract
AIM
To report our initial experience with lens-sparing vitrectomy for stage 4 retinopathy of prematurity using the 27-gauge (G) system.
METHODS
This retrospective case series involved nine eyes of five babies with active stage 4 ROP, who underwent 27-G lens-sparing vitrectomy. Surgery was done using 27-G valved cannulas and sclerotomies were made 1.5 mm from the limbus. Bilateral sequential vitrectomy was done in eight eyes.
RESULTS
At one-year follow-up, anatomical outcome was favourable in all nine (100%) eyes. High-speed cutting and smaller sclerotomies were helpful in reducing the intra and post-operative complications.
CONCLUSION
27-G vitrectomy is well suited for stage 4 ROP surgeries.
Core tip: This is a retrospective study of nine eyes of five children with active stage 4 retinopathy of prematurity, who underwent 27-gauge microincision vitrectomy surgeries with excellent outcomes.
